Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed by Selective Capecitabine-Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer

Purpose To evaluate, in a phase 2 study, the safety and efficacy of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer (BRPC or LAPC, respectively). Method...

Full description

Saved in:
Bibliographic Details
Published in:International journal of radiation oncology, biology, physics Vol. 88; no. 4; pp. 837 - 844
Main Authors: Esnaola, Nestor F., MD, Chaudhary, Uzair B., MD, O'Brien, Paul, MD, Garrett-Mayer, Elizabeth, PhD, Camp, E. Ramsay, MD, Thomas, Melanie B., MD, Cole, David J., MD, Montero, Alberto J., MD, Hoffman, Brenda J., MD, Romagnuolo, Joseph, MD, Orwat, Kelly P., MD, Marshall, David T., MD
Format: Journal Article
Language:English
Published: United States Elsevier Inc 15-03-2014
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first